Actively Recruiting

Age: 40Years - 101Years
All Genders
NCT06323876

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

Led by University of Virginia · Updated on 2024-08-16

160

Participants Needed

1

Research Sites

253 weeks

Total Duration

On this page

Sponsors

U

University of Virginia

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This observational study involves obtaining 2 chest CT scans; a historical baseline CT within ±1 year of enrollment into PRECISIONS, and a follow-up CT (either historical or prospective) 12 months ± 180 days after the baseline CT. Many IPF patients will have a CT scan every 12 months for disease monitoring and cancer screening. Participants will have the option to share historical CTs only or they can choose to have a research CT done for the follow-up scan, if a scan for clinical purposes is not available.

CONDITIONS

Official Title

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

Who Can Participate

Age: 40Years - 101Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 40 years of age or older
  • Diagnosed with idiopathic pulmonary fibrosis (IPF) as confirmed by the enrolling investigator following 2018 ATS/ERS/JRS/ALAT guidelines
  • Signed informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Pregnancy or planning to become pregnant
  • Women of childbearing potential unwilling to remain abstinent or use two effective contraception methods during the study
  • Significant medical, surgical, or psychiatric illness that may affect safety or study completion as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Virginia

Charlottesville, Virginia, United States, 22908

Actively Recruiting

Loading map...

Research Team

R

Roselove Nunoo-Asare

CONTACT

D

Diana Hsu, MA

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here